DURECT Corporation - Common Stock (NQ:DRRX)

1.910 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DURECT Corporation - Common Stock

< Previous 1 2 3 4 Next >

Crude Oil Falls 2.5%; Ralph Lauren Posts Upbeat Earnings ↗

November 08, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling around 80 points on Wednesday The Dow traded down 0.23% to 34,074.30 while the NASDAQ fell 0.01% to 13,638.07. The...

Via Benzinga

Topics Stocks

Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 08, 2023

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday.

Via Benzinga

Why Is Pain & Liver Disease Focused DURECT Stock Plunging Today? ↗

November 08, 2023

DURECT Corporation (NASDAQ: DRRX) released topline

Via Benzinga

Earnings Outlook For Durect ↗

August 08, 2023

Via Benzinga

Analyst Ratings for Durect ↗

May 17, 2023

Via Benzinga

Dow Falls Over 100 Points; US Wholesale Inventories Edge Higher ↗

November 08, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 100 points on Wednesday The Dow traded down 0.33% to 34,038.81 while the NASDAQ fell 0.28% to 13,601.60. The S&P 500...

Via Benzinga

Topics Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

November 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 08, 2023

Via Benzinga

US Stocks Higher; Kellanova Sales Top Estimates ↗

November 08, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 90 points on Wednesday Following the market opening Wednesday, the Dow traded up 0.27% to 34,244.50 while the NASDAQ rose 0.20%...

Via Benzinga

Topics Stocks

Durect Earnings Preview ↗

May 05, 2023

Via Benzinga

Durect Corp. (NASDAQ: DRRX) Making Surprising Moves in Monday Session

April 10, 2023

Via Investor Brand Network

Cantor Fitzgerald Is Souring on Lucid Motors (LCID) Stock ↗

November 08, 2023

Lucid Motors stock is falling after Cantor Fitzgerald analysts downgraded LCID shares and cut their price target following its Q3 earnings.

Via InvestorPlace

Why Is Sleep Number (SNBR) Stock Down 40% Today? ↗

November 08, 2023

Sleep Number stock is falling on Wednesday as investors in SNBR react to the company missing EPS and revenue estimates for Q3.

Via InvestorPlace

Why Is Durect (DRRX) Stock Down 64% Today? ↗

November 08, 2023

Durect stock is taking a beating on Wednesday as DRRX investors react to results from a Phase 2b clinical trial of larsucosterol.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 08, 2023

Via Benzinga

Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗

November 08, 2023

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 08, 2023

Pre-market stock movers are a hot topic on Wednesday and we're starting the morning with a breakdown of the biggest ones.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 02, 2023

Via Benzinga

3 Promising Biotech Stocks That Will Make Early Investors Rich ↗

October 02, 2023

Despite their volatility, certain biotech stocks stand out for their innovative approaches and potential game-changing therapies.

Via InvestorPlace

Why AMC Entertainment Holdings Shares Are Trading Higher By 41%; Here Are 20 Stocks Moving Premarket ↗

July 24, 2023

Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) rose 45% to $0.2890 in pre-market trading after falling over 8% on Friday.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 24, 2023

On Monday morning, 70 companies achieved new lows for the year.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

July 24, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 20, 2023

Via Benzinga

Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 20, 2023

Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements.

Via Benzinga

Nasdaq Down 50 Points; Tesla Earnings Beat Expectations ↗

July 20, 2023

U.S. stocks traded mixed this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.40% to 35,202.41 while the NASDAQ fell 0.35% to...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 20, 2023

Via Benzinga

What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur ↗

May 22, 2023

On Friday, FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceutical Inc's ICPT Ocaliva 25 mg, also known as Obeticholic acid...

Via Benzinga

7 Biotech Stocks Sitting in the Sweet Spot ↗

March 24, 2023

Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 ↗

March 14, 2023

Via Benzinga

Tesla To Rally More Than 12%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

March 08, 2023

HC Wainwright & Co. cut the price target for DURECT Corporation (NASDAQ: DRRX) from $35 to $32. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. DURECT shares fell 1.3% to close at $4.75 on...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.